IntelliCyt Cy-Clone™ PLUS
Introducing Cy-Clone™ PLUS—the only one assay, one platform method for rapidly identifying and selecting production clones. Traditionally ranked by IgG titer alone, Cy-Clone PLUS provides a more complete picture of the critical productivity attributes that drive optimal clone selection. The Cy-Clone PLUS Kit and the iQue® Screener PLUS platform combine IgG titer, cell viability, and cell count in every well of a 96-well plate in <5 minutes (384-wells < 20 minutes).
Related content from this organisation
- High throughput flow cytometry for multifactorial evaluation of novel therapeutic candidates using an innovative In vitro immuno-oncology screening platform
- Expert view: Addressing the big challenges in drug screening
- Screening In-Depth Focus 2017
- Whitepaper: Advancing therapeutic antibody discovery with multiplexed screening
- Advancing the discovery of immunotherapeutics with large scale multiplexed experiments